Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin a
Open Access
- 1 September 1990
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (9) , 1310-1316
- https://doi.org/10.1002/art.1780330902
Abstract
Thirty-one patients with seropositive rheumatoid arthritis treated with cyclosporin A (CsA) were evaluated for immune function prior to, during, and after 1 year of therapy. Patients whose pretreatment peripheral blood mononuclear cells were hypoproliferative in vitro to soluble recall antigens responded better clinically to CsA treatment than did the other patients. During therapy, proliferative responses became normal and remained so until 1–2 months after CsA was discontinued. At that time, the lymphocyte proliferation defect reappeared. In addition, patients who responded clinically to CsA had a higher percentage of Leu-7+ natural killer cells in their peripheral blood prior to therapy. All patients exhibited greater frequencies of cells that expressed interleukin-2 receptors, which decreased with CsA treatment. The clinical response to CsA appears to be associated with distinct immunologic parameters in rheumatoid arthritis.This publication has 20 references indexed in Scilit:
- Cyclosporin A in Severe, Treatment-Refractory Rheumatoid ArthritisAnnals of Internal Medicine, 1988
- Humoral immune function in severe, active rheumatoid arthritisClinical Immunology and Immunopathology, 1987
- Cyclosporin a in rheumatoid arthritis: preliminary clinical results of an open trialArthritis & Rheumatism, 1987
- An Open, Controlled, Randomized Comparison of Cyclosporine and Azathioprine in the Treatment of Rheumatoid Arthritis: A Preliminary ReportArthritis & Rheumatism, 1987
- Cyclosporin A inhibits antigen‐ and lectin‐induced but not constitutive production of interleukin 3European Journal of Immunology, 1985
- Rheumatoid Arthritis: Evolving Concepts of Pathogenesis and TreatmentAnnals of Internal Medicine, 1984
- Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.Journal of Clinical Investigation, 1984
- Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.Proceedings of the National Academy of Sciences, 1984
- Leukapheresis in rheumatoid arthritis association of clinical improvement with reversal of anergyArthritis & Rheumatism, 1983
- Gamma Interferon Synthesis by Human Thymocytes and T Lymphocytes Inhibited by Cyclosporin AScience, 1983